Quantitation of tenofovir and emtricitabine in dried blood spots (DBS) with LC-MS/MS.
about
Advantages and Challenges of Dried Blood Spot Analysis by Mass Spectrometry Across the Total Testing ProcessGender-Specific Combination HIV Prevention for Youth in High-Burden Settings: The MP3 Youth Observational Pilot Study Protocol.A randomized clinical pharmacokinetic trial of Tenofovir in blood, plasma and urine in adults with perfect, moderate and low PrEP adherence: the TARGET study.Comparing the novel method of assessing PrEP adherence/exposure using hair samples to other pharmacologic and traditional measuresClinical Treatment Options Infectious Diseases: Update on PrEP Implementation, Adherence, and Advances in DeliveryTherapeutic drug monitoring by dried blood spot: progress to date and future directions.Procedures and practices for the validation of bioanalytical methods using dried blood spots: a review.Development, validation and clinical application of a method for the simultaneous quantification of lamivudine, emtricitabine and tenofovir in dried blood and dried breast milk spots using LC-MS/MS.Urine assay for tenofovir to monitor adherence in real time to tenofovir disoproxil fumarate/emtricitabine as pre-exposure prophylaxis.Decline in Bone Mass With Tenofovir Disoproxil Fumarate/Emtricitabine Is Associated With Hormonal Changes in the Absence of Renal Impairment When Used by HIV-Uninfected Adolescent Boys and Young Men for HIV Preexposure Prophylaxis.An Investigation of Liquid Chromatography-Mass Spectral Attributes and Analytical Performance Characteristics of Tenofovir, Emtricitabine and Efavirenz in Human Plasma.Identification of a novel human circulating metabolite of tenofovir disoproxil fumarate with LC-MS/MS.Novel quantification of tenofovir disoproxil fumarate adherence in human immunodeficiency virus/hepatitis B coinfected patients with incomplete hepatitis B virus viral suppression.Predictors of Over-Reporting HIV Pre-exposure Prophylaxis (PrEP) Adherence Among Young Men Who Have Sex With Men (YMSM) in Self-Reported Versus Biomarker Data.Adherence Measurements in HIV: New Advancements in Pharmacologic Methods and Real-Time Monitoring.A LC-MS/MS Method for Quantifying Adenosine, Guanosine and Inosine Nucleotides in Human Cells.Plasma and breast milk pharmacokinetics of emtricitabine, tenofovir and lamivudine using dried blood and breast milk spots in nursing African mother-infant pairs.What is the right blood hematocrit preparation procedure for standards and quality control samples for dried blood spot analysis?
P2860
Q29109543-331B9299-A7D8-4065-9F36-014A9C042576Q33697680-F08CF1F2-E2D4-43C1-ACC5-B70A573F7DBDQ33909720-0BA5892A-0555-4CFB-81A8-AB76680631A3Q34675000-C17EB6A2-8169-424A-8527-7DA40F860068Q35541521-F30494F5-B658-4AB7-BF13-CEEBA7B099A4Q38247481-0339679E-06BA-41E7-AABA-0CF1F32594B5Q38266632-D9CBB928-7823-4DF3-8559-B2ACD42958DDQ38849874-931376CC-1D6C-42B4-9A75-0D23EBDD08A8Q40227281-8A35B838-F53F-4D86-BEB1-7F90718D97E4Q40396204-B3B5A0BD-1060-4F8B-A81C-DD1F11E48FE6Q40793702-390814E4-03E6-42AB-82CB-6FB341018183Q41336340-62FF47C0-00E7-4A14-88B9-8F4FF68FB85AQ42408717-9C5AAE27-3C16-4E71-9064-ACC56D4541DBQ46514187-4E98EA7D-4D07-4A0C-A178-17B9B5037BDAQ49587788-942A86D2-70E4-45A2-830C-A9459F96E778Q49810962-1C07928E-B515-4D08-BB5C-A7E770D0907EQ50138591-F826AEF1-2114-4AB1-8E7B-476C27CD1602Q50584403-B18424C7-D2E6-49D0-A870-EEFC2F4CFA9E
P2860
Quantitation of tenofovir and emtricitabine in dried blood spots (DBS) with LC-MS/MS.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 31 August 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Quantitation of tenofovir and emtricitabine in dried blood spots (DBS) with LC-MS/MS.
@en
Quantitation of tenofovir and emtricitabine in dried blood spots
@nl
type
label
Quantitation of tenofovir and emtricitabine in dried blood spots (DBS) with LC-MS/MS.
@en
Quantitation of tenofovir and emtricitabine in dried blood spots
@nl
prefLabel
Quantitation of tenofovir and emtricitabine in dried blood spots (DBS) with LC-MS/MS.
@en
Quantitation of tenofovir and emtricitabine in dried blood spots
@nl
P2093
P2860
P1476
Quantitation of tenofovir and emtricitabine in dried blood spots (DBS) with LC-MS/MS.
@en
P2093
Amie Meditz
Becky Jo Kerr
Brandon Klein
Caitlin Rower
Jacob Langness
Jennifer Kiser
Jia-Hua Zheng
Jose Castillo-Mancilla
Lane Bushman
Louis A Guida
P2860
P304
P356
10.1016/J.JPBA.2013.08.033
P577
2013-08-31T00:00:00Z